Untargeted metabolomics can decide hereditary variation to improve understanding finding Kumar Jeetendra | July 8, 2020 A family and patient walk into a physician’s office. They expect that the most recent tests will show what’s causing the individual’s disease and finish the diagnostic odyssey they’ve been going through for ages. Possessing a precise identification also suggests that perhaps there’s a remedy that can relieve the individual’s condition. To identify the genetic …
Nex gen SCIEX 7500 System dispatches at virtual product experience Kumar Jeetendra | July 11, 2020 SCIEX, a worldwide leader in life engineering analytic technologies, launches another generation of its flagship nominal mass spectrometer, the SCIEX Triple Quad™ 7500 LC-MS/MS System — QTRAP® Ready. This technique delivers the maximum level of sensitivity in the SCIEX portfolio also empowers clients to go beyond previous constraints. The 7500 System is going to absolutely …
Specialists utilize new way to deal with unwind the systems that lie behind tetraploidy Kumar Jeetendra | July 25, 2020 Cell division is a fundamental process that organisms need to replicate, expand, and make repairs. But when a mistake accomplishes this complex biological process, cellular abnormalities may lead to ailments, for example cancer, where cells are enabled to grow and divide out of control. Their findings were published on April 29 at eLife, an open-access …
Harbour BioMed and Viva Biotech declare key coordinated effort to promote biotech new startups Kumar Jeetendra | August 1, 2020 HBM will combine its top Harbour Mice® stage H2L2 and its expertise in global research and development of innovative molecules, with Viva Biotech’s structure-based early phase drug discovery services. This complementary partnership will provide advanced biotech startups access to next generation technologies that create synergies to accelerate the route between ideation to merchandise. The incubated …
Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer Kumar Jeetendra | October 28, 2020 In this new role, Stewart will work as part of the Executive staff to drive Adaptate’s Business and Corporate Development activities. Stewart Kay, CBO, Adaptate Biotherapeutics Adaptate is developing a range of therapeutic antibodies that recognize drug targets and have the potential to modulate the activity of gamma delta T cells. Gamma delta T cells …
Researchers develop insect sex pheromones in transgenic camelina plant for maintainable pest control Kumar Jeetendra | January 15, 2021 The camelina plant, a source of cooking oil for centuries, is on its way toward revolutionizing pest management in agriculture. Researchers at ISCA, Inc., a green agtech firm based in Riverside, Calif., and their collaborators in Sweden have “grown” insect sex pheromone precursors in genetically modified strains of camelina plants, creating a low-cost source of …
FDA issues emergency use approval for T-Detect COVID Test Kumar Jeetendra | March 7, 2021 Now, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for its T-Detect COVID Exam developed by Adaptive Biotechnologies. The T-Detect COVID Evaluation is a next generation sequencing established (NGS) test to assist in identifying people with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2. …
Intense openness of lung tissue to vape airborne lesserly affects gene expressionthan cigarette smoke Kumar Jeetendra | March 21, 2021 A new peer-reviewed study published in the journal Toxicological Research & Application reveals acute exposure of a 3D human bronchial tissue model to e-cigarette aerosol has minimal impact on gene expression in contrast to smoke from combustible cigarettes. The study included sub-cytotoxic vulnerability to cells in a 3D human bronchial model (MucilAirTM) to nicotine-containing vape …
New testing protocols for SARS-CoV-2 can handle a huge number of tests inside 48 hours Kumar Jeetendra | May 25, 2021 Researchers in the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is printed in the journal Nature Communications and might be adapted to many more pathogens. The COVID-19 pandemic has lasted more than a year and continues to …
